To decipher the relevant molecular mechanisms of SMYD3 in SCLC, we performed biochemical screening, which identified the E3-ubiquitin ligase RING finger protein 113A (RNF113A) as a novel substrate. The gene discussed is SMYD3; the disease is small cell lung carcinoma.